Johannes H Voigt

This inventor holds 22 USPTO granted patents, plus 1 CIPO patent and 9 EPO patents, primarily in Protease Inhibitors. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Pharmacopeia Drug Discovery, Inc.. Active years: 2005-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes H Voigt. Retrieved from https://idiyas.com/inventor/johannes-h-voigt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 95.5

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 2)

Average Co-Inventor Count = 8.7

ph-index = 6

Forward Citations = 119(Granted Patents)

Location History:

Union, NJ (US) (2005 - 2012)
Cranford, NJ (US) (2007 - 2014)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

3 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

4. 2 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Schering-Plough Corporation

patents

7. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2005-2014

Loading Chart...

Areas of Expertise:

Fatty Acid Binding Protein

Heterocyclic Compounds

Aspartyl Protease

Macrocyclic Inhibitors

BACE-1 Inhibitors

Gamma Secretase

Cyclic Amines

SH2 Domain Binding

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8889683 - Substituted quinoxalines as inhibitors of fatty acid binding protein (2014-11-18),

2. 8815875 - Inhibitors of fatty acid binding protein (FABP) (2014-08-26),

3. 8778980 - Heterocyclic aspartyl protease inhibitors (2014-07-15),

4. 8759357 - Inhibitors of fatty acid binding protein (FABP) (2014-06-24),

5. 8557798 - Macrocyclic heterocyclic aspartyl protease inhibitors (2013-10-15),

6. 8357682 - Gamma secretase modulators (2013-01-22),

7. 8278334 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2012-10-02),

8. 8242112 - Heterocyclic aspartyl protease inhibitors (2012-08-14),

9. 8178513 - Heterocyclic aspartyl protease inhibitors (2012-05-15),

10. 8012953 - Macrocyclic beta-secretase inhibitors (2011-09-06),

11. 7973067 - Heterocyclic aspartyl protease inhibitors (2011-07-05),

12. 7910590 - Cyclic amine bace-1 inhibitors having a heterocyclic substituent (2011-03-22),

13. 7868000 - Aspartyl protease inhibitors (2011-01-11),

14. 7812013 - Macrocyclic heterocyclic aspartyl protease inhibitors (2010-10-12),

15. 7763609 - Heterocyclic aspartyl protease inhibitors (2010-07-27),

Title: Johannes H Voigt: Pioneering Inventor from Cranford, NJ

Introduction: Johannes H Voigt is a distinguished inventor hailing from Cranford, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Johannes H Voigt holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: With a career spanning over two decades, Voigt has consistently pushed the boundaries of innovation, leading to the development of revolutionary products that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Johannes H Voigt has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing that has propelled his inventions to new heights.

Conclusion: Johannes H Voigt's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his position as a trailblazing inventor shaping the future of technology.

Profile summary based on public USPTO records.